Skip to content
Search AI Powered

Latest Stories

Blunt Take: Athletic Cannabis Bans and the Big Pharma Influence

Is Big Pharma behind WADA's cannabis ban? Probably.
Is Big Pharma behind WADA's cannabis ban? Probably.
Image by Gerhard from Pixabay

The World Anti-Doping Agency (WADA) has kept cannabis on its list of banned substances for 2023.

The list was finalized on Sept 23.


According to the Wall Street Journal, “WADA’s Prohibited List Expert Advisory Group has backed keeping a ban in place, saying that based on the scientific evidence available, the drug meets the criteria for inclusion on the list.”

WADA, which handles athletic drug testing for the Olympics and other sports, was urged by the U.S. Anti-Doping Agency last year to review its approach to cannabis after the controversial suspension of American sprinter Sha’Carri Richardson last year.

Richardson was suspended from participating in the Tokyo games after previously consuming cannabis in Oregon, where the plant has been medically legal since 1998 and legal for all adults since 2014.

In response to the outcry, WADA promised to initiate a scientific review of cannabis and is now leaning toward a continued ban.

But why? What scientific evidence did they review exactly?

What’s the concern with athletes using cannabis as part of their regimen?

Is Weed a Performance-Enhancing Substance?

The whole point of WADA’s existence is to prevent cheaters from spoiling the competition.

This message is loud and clear on the homepage of their website: “Raising the game for clean sport.”

Do they then consider cannabis as a performance enhancer? What other reason to ban it?

It’s not uncommon to hear of creatives getting dialed in at work with just the right dose of cannabinoids, or athletes enjoying invigorated exercise routines with improved recovery time thanks to cannabis’s anti-inflammatory properties.

Or what about athletes governed under WADA’s policies who could use cannabis to help with sleep, stress, and anxiety?

This doesn’t sound like a performance-enhancing drug at all because an optimized cannabis regimen is all about restoring balance and harmony to the body and the mind.

Imagine if WADA banned nutritional supplements. Imagine if they banned meditation. Sounds extreme right? Or what if they banned antidepressants or anti-inflammatories?

What’s wrong with an athlete who can learn how to use cannabis to take better care of themselves and maybe even improve the longevity of their career?

Frankly, this is a win-win scenario unless you’re Big Pharma still trying to peddle pill-shaped solutions.

The Big Pharma Factor

WADA’s Prohibited List Expert Advisory Group is heavily comprised of people who come from Big Pharma.

You can double check the group members over at WADA’s website for yourself. Even group chair Dr. Audrey Kinahan has a robust background in the pharmaceutical industry.

What’s more, they don’t consider cannabis a performance enhancer at all. It’s just a banned substance. In fact, athletes can get a Therapeutic Use Exemption (TUE) for it.

It’s no secret that Big Pharma has a vested interest in cannabis prohibition.

Over the years, Big Pharma has actively played a role in slowing cannabis progress through legislative lobbying (aka legalized bribery) and the funding of anti-cannabis propaganda.

Why would people want pills with harsh side effects when the right amount of cannabis at the right time seems to do a better job?

It was recently reported that the pharmaceutical industry is losing billions to the cannabis space, and they’re no doubt scratching and clawing out of sheer self-preservation.

When you consider how the industry’s business model relies on people getting or staying sick, how can you trust anything with their fingerprints on it?

Banning and Testing for THC is Problematic and Unfair

WADA’s continued ban of cannabis shows how little they care about science or the health of athletes.

“The problem with the testing of ‘marijuana’ (or THC) versus other substances is the duration of time in which is it detectable,” said Codi Peterson, Chief Science Offer at The Cannigma.

“Many drugs are long gone compared to THC metabolites which can linger for a while.”

In other words, weed can stay in your system for a long time, and you can still fail a drug test even if you haven’t consumed any THC for a few days, or sometimes longer.

And even then, does it really make sense to be testing for THC/cannabis in the first place?

“It’s cruel to expect athletes to perform for others’ entertainment, and not allow them to recover with humane treatments. WADA is shameful,” said Mara Gordon, founder of Aunt Zelda’s, which has helped thousands of chronically ill patients and their doctors integrate medical cannabis regimens into conventional treatment protocols.

Diana McElroy, a lifestyle wellness coach and yoga instructor also chimed in with her experience. “Cannabis is a medicine and helps people with inflammation and body aches. Athletes in particular benefit greatly.”

Of course, WADA will need more than just anecdotal reports to make an informed decision to lift the ban on cannabis.

But what info are they looking for exactly, other than Big Pharma stock ratings?

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

Keep Reading Show less
Cannabis Industry in Crisis According to New Research
Cannabis Industry in Crisis According to New Research

Cannabis Industry in Crisis According to New Research

Whitney Economics, a prominent cannabis economics data, consulting, and research firm, has recently released its second annual Cannabis Operator Sentiment and Business Conditions survey report. The report, based on an extensive survey of U.S. cannabis business licensees, examines the perspectives of industry operators on their success and the barriers they face.

The survey assessed shortages and surpluses in materials, services, and labor inputs in relation to future expectations. It also revealed key business metrics such as revenues, profits, margins, and costs.

Keep Reading Show less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep Reading Show less
OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
Photo by Jon Tyson on Unsplash

NY Revokes License in Rent-a-License Scam

Update to our coverage: Since this article was originally published, the enforcement case against Omnium Health has taken a sharp and unexpected turn. On December 8, 2025, New York’s Office of Cannabis Management abruptly withdrew the charges underpinning the license revocation, triggering leadership shakeups inside the agency and raising new questions about how the case was built and handled.

While regulators moved to step back, an administrative law judge declined to immediately dismiss the matter, leaving the door open to potential future action and lifting the recall order on roughly $30 million in Omnium products. We will continue to update this story as the situation develops.

Keep Reading Show less
map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct

Legal Weed, Legit?

New York’s legal cannabis industry was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report by The New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call inversion—and it’s been the industry’s not-so-secret open secret for years.

Keep Reading Show less